BackNeuroBo Pharmaceuticals Overview

NeuroBo Pharmaceuticals Inventory

Track NeuroBo Pharmaceuticals's inventory ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$0.00

Peer average

Loading

NeuroBo Pharmaceuticals Inventory History

Loading

NeuroBo Pharmaceuticals vs. peers: Inventory Comparison

Loading

NeuroBo Pharmaceuticals Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NeuroBo Pharmaceuticals (NRBO) FAQ

NeuroBo Pharmaceuticals (NRBO) currently reports a inventory of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore NeuroBo Pharmaceuticals's inventory history and peer comparisons.

NeuroBo Pharmaceuticals's inventory changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NeuroBo Pharmaceuticals reported $0 in inventory as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NeuroBo Pharmaceuticals, and consider following NRBO for alerts when major investors trade the stock.

NeuroBo Pharmaceuticals is classified in the Healthcare sector. On inventory, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NRBO with unrelated industries.